Cytomegalovirus retinitis: are intraocular devices the answer?
Tufail
A
A
UCLA Ocular Inflammatory Disease Center, Department of Ophthalmology, UCLA School of Medicine, USA.
Holland
G N
GN
D000998:Antiviral Agents / Q000008:administration & dosage*; D017726:Cytomegalovirus Retinitis / Q000517:prevention & control*; D018450:Disease Progression; D004343:Drug Implants / Q000009:adverse effects; D015774:Ganciclovir / Q000008:administration & dosage*; D006801:Humans
D000998:Antiviral Agents; D004343:Drug Implants; D015774:Ganciclovir